# Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease

> **NCT02600130** · PHASE1 · COMPLETED · sponsor: **Longeveron Inc.** · enrollment: 33 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **BIOLOGICAL:** Longeveron Mesenchymal Stem Cells
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02600130
- **Lead sponsor:** Longeveron Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-10
- **Primary completion:** 2020-09
- **Final completion:** 2021-09
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02600130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02600130, "Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02600130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*